NeurAxis, Inc. (NRXS)
NYSEAMERICAN: NRXS · Real-Time Price · USD
7.61
-0.52 (-6.40%)
Apr 28, 2026, 4:00 PM EDT - Market closed
NeurAxis Employees
NeurAxis had 24 employees as of December 31, 2025. The number of employees increased by 3 or 14.29% compared to the previous year.
Employees
24
Change (1Y)
3
Growth (1Y)
14.29%
Revenue / Employee
$148,720
Profits / Employee
-$358,965
Market Cap
87.56M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 24 | 3 | 14.29% |
| Dec 31, 2024 | 21 | 2 | 10.53% |
| Dec 31, 2023 | 19 | 1 | 5.56% |
| Dec 31, 2022 | 18 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 213 |
| Gossamer Bio | 162 |
| Inovio Pharmaceuticals | 112 |
| Adicet Bio | 102 |
| PolyPid | 75 |
| Rani Therapeutics Holdings | 71 |
| eXoZymes | 32 |
| Q32 Bio | 24 |
NRXS News
- 6 days ago - NeurAxis Expands Payer Coverage with Four New Medical Policies - GlobeNewsWire
- 18 days ago - NeurAxis, Inc. Announces Preferred Stock Dividend - GlobeNewsWire
- 5 weeks ago - NeurAxis Earnings Call Transcript: Q4 2025 - Transcripts
- 5 weeks ago - NeurAxis Reports Strong Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 3 months ago - NeurAxis Transcript: 2nd Annual Lytham Partners Healthcare Investor Summit - Transcripts
- 6 months ago - NeurAxis Earnings Call Transcript: Q3 2025 - Transcripts
- 6 months ago - NeurAxis Reports Strong Third Quarter 2025 Financial Results Driven by a 22% Growth in Revenues - GlobeNewsWire
- 7 months ago - NeurAxis Transcript: Lytham Partners Fall 2025 Investor Conference - Transcripts